Healis, Sekhsaria Institute for Public Health, Navi Mumbai, India.
Am J Hypertens. 2009 Oct;22(10):1076-84. doi: 10.1038/ajh.2009.131. Epub 2009 Jul 23.
To determine all-cause and circulatory system (cardiovascular)-related mortality in subjects with different grades of hypertension, we performed a prospective study.
A total of 148,173 individuals aged > or =35 years were recruited in Mumbai, India in years 1991-1997. Clinical history and anthropometric data were obtained and hypertension-categorized using US 7th Joint National Committee guidelines into normal, prehypertension, stage-I, and stage-II. These subjects were followed to ascertain vital status from 1997 to 2003. Multivariate analysis was performed using Cox proportional analyses and adjusted hazard ratios (HRs), 95% confidence intervals (CIs) determined for mortality in various hypertension grades.
At baseline, hypertension was in 47.3% men and 45.7% women, while prehypertension in 40.8% men and 35.9% women. In total, 13,261 persons died during average 5.5 years follow-up of whom 9,259 deaths were matched and coded using International Classification of Diseases-10. Compared to those with normal blood pressure (BP), all cause mortality (HR, 95% CI) was significantly greater in stage-II (men 1.41, 1.31-1.52; women 1.46, 1.30-1.64). Circulatory system deaths were significantly more in stage-II (men 2.05, 1.77-2.39; women 2.06, 1.62-2.61) as well as stage-I (men 1.31, 1.14-1.52; women 1.39, 1.10-1.77). Subjects with stage-II hypertension had greater risk of death from hypertensive heart disease (men 2.77, 1.75-4.40; women 3.04, 1.73-5.35), ischemic heart disease (men 1.87, 1.54-2.28; women 1.85, 1.29-2.65), and cerebrovascular diseases (men 3.50, 2.42-5.05; women 3.09, 1.77-5.39).
In urban Indian subjects, compared to normal BP stage-II hypertension is associated with increased risk of all-cause mortality, while both stage-II and stage-I hypertension with circulatory system-related mortality.
为了确定不同程度高血压患者的全因死亡率和循环系统(心血管)相关死亡率,我们进行了一项前瞻性研究。
1991 年至 1997 年在印度孟买招募了 148173 名年龄≥35 岁的个体。通过美国第七联合国家委员会指南获得临床病史和人体测量数据,并将高血压分为正常、高血压前期、I 期和 II 期。从 1997 年到 2003 年,对这些受试者进行随访以确定其生存状态。使用 Cox 比例分析进行多变量分析,并确定各种高血压程度下死亡率的调整后危险比 (HR) 和 95%置信区间 (CI)。
基线时,男性高血压患病率为 47.3%,女性为 45.7%,而男性高血压前期患病率为 40.8%,女性为 35.9%。在平均 5.5 年的随访期间,共有 13261 人死亡,其中 9259 人死亡与国际疾病分类第 10 版相匹配并编码。与正常血压 (BP) 相比,II 期高血压患者的全因死亡率 (HR,95%CI) 显著更高 (男性 1.41,1.31-1.52;女性 1.46,1.30-1.64)。循环系统死亡在 II 期高血压患者中更为明显 (男性 2.05,1.77-2.39;女性 2.06,1.62-2.61) 以及 I 期高血压患者中更为明显 (男性 1.31,1.14-1.52;女性 1.39,1.10-1.77)。II 期高血压患者死于高血压性心脏病的风险更高 (男性 2.77,1.75-4.40;女性 3.04,1.73-5.35)、缺血性心脏病 (男性 1.87,1.54-2.28;女性 1.85,1.29-2.65) 和脑血管疾病 (男性 3.50,2.42-5.05;女性 3.09,1.77-5.39)。
在印度城市人群中,与正常血压相比,II 期高血压与全因死亡率的增加相关,而 II 期和 I 期高血压与循环系统相关死亡率相关。